Stay up to date with the latest news and events from the NIHR Manchester Biomedical Research Centre.
In the third blog in our ‘addressing health inequalities in research’ series, our Data Management Lead, Gareth Adaway, discusses the role data plays in our work.
Continue reading full article: How we are using data to address health inequalities in research
Part of our regular Rapid Translational Incubator events and webinars, this webinar will provide an overview of sponsorship processes at the University of Manchester.
Continue reading full article: Webinar – Sponsorship advice for trials and studies – 28.04.2020
Manchester BRC researchers have launched a trial on a bedside genetic test that will predict whether newborn babies receiving antibiotics in intensive care are at risk of irreversible hearing loss.
Continue reading full article: Manchester BRC’s emergency genetic test could prevent antibiotic – related hearing loss in newborns
In the second blog in our ‘addressing health inequalities in research’ series, our Public Programmes Project Manager for Communities and Inclusion, Tracy Grey, discusses some of the health inequalities that persist in our Greater Manchester population and why.
Continue reading full article: Health inequalities in Greater Manchester – why they exist and what we are doing to address it
Hearing Health Lead Professor Kevin Munro has become a Principal Fellow of The British Society of Audiology (BSA) and North West Committee Chair of the NIHR Research for Patient Benefit (RfPB) programme.
Continue reading full article: Dual honours for Manchester BRC Hearing Health Lead
Manchester BRC Hearing Health Lead Kevin Munro welcomes the launch of the “Hearing Medicines Discovery Syndicate,”a unique collaboration to accelerate the much-needed development of treatments for hearing loss and tinnitus.
Continue reading full article: Manchester BRC in unique collaboration to accelerate the development of hearing loss treatments
The first global patient has taken part in a clinical trial testing the effectiveness and safety of a new treatment for a rare inflammatory muscle disease. Professor Hector Chinoy is the UK chief investigator of the study and Dr James Lilleker is a sub-investigator. Both are BRC researchers within
Continue reading full article: First global patient takes part in trial of new drug to treat rare inflammatory muscle disease
In the first instalment in our new blog series, Dr Bella Starling, Co-Director of Public Programmes, discusses the benefits translational research can have for society as a whole.
Continue reading full article: How can translational research benefit those who might need it the most?